GAICD, MIP Law, Dr rer Nat

Felicia Pradera is Director of Moderna’s Regional Research Centre and Strategic Alliances in Melbourne, leading R&D collaboration across Australia and the Indo Pacific and representing Moderna on national innovation platforms. With over 20 years’ experience in research, policy and product development, she has advised national and international governments on medical countermeasures (MCM), health security and pandemic response, including briefing the US National Security Council in 2018. Previously, she led MCM development at the Defence Science and Technology Group, established Australia’s national MCM program, and chaired the Quadrilateral MCM Consortium, later heading Health Security Systems Australia at DMTC Limited. During COVID 19, she served on the Prime Minister’s Science and Industry Technical Advisory Group and various Defence Committees. She holds a PhD in Biotechnology, a Master of Intellectual Property Law, and a BSc (Hons), and is a non-executive director of M:MBio and ThirtyFiveBio.